Diabetes: Significance of HbA1c Testing
An inaccurate test report may lead an unsuspecting clinician to make wrong patient care decisions. How can clinical laboratories avoid incorrect HbA1c results?
The Everlife-Lifeline Team received 4 awards in the Bio-Rad SEA Sales meeting held at Siem Riep, Cambodia last February 13-14.
The company achieved significant recognitions namely:
SEA Country of the Year 2022- Blood Bank Segment
SEA Country of the Year 2022- Gene Expression Business Unit
SEA Continuous Growth Award 2022 - Life Science Group
SEA Life Science Group Distributor of the Year 2022
The meeting was attended by the Everlife-Lifeline Diagnostics team, headed by its President and Founder, Mr. Rex A. Tiri, as well as representatives from Everlife Chemoscience, and Raman Gandotra, CEO of Everlife Asia, in support to its 2 subsidiaries for Philippines and Malaysia.
Bio-Rad is a global leader in developing, manufacturing, and marketing a broad range of innovative products for life science research and clinical diagnostic markets. The annual meeting was attended by various Diagnostics and Medical Equipment Suppliers from Southeast Asia.
The awards received by Everline-Lifeline reflect the company’s dedication to excellence, innovation, and customer satisfaction. As it celebrates its achievements, the company remains committed to its mission to improve the healthcare system in the Philippines and enable better outcomes.